X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12983) 12983
Magazine Article (17) 17
Book / eBook (6) 6
Conference Proceeding (3) 3
Web Resource (3) 3
Dissertation (2) 2
Publication (2) 2
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (12870) 12870
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (8189) 8189
male (7330) 7330
female (7062) 7062
child (6381) 6381
adolescent (5044) 5044
oncology (5041) 5041
hematology (4952) 4952
child, preschool (4495) 4495
adult (3446) 3446
antineoplastic combined chemotherapy protocols - therapeutic use (3026) 3026
infant (2716) 2716
children (2708) 2708
leukemia (2576) 2576
cancer (2490) 2490
pediatrics (2408) 2408
chemotherapy (2329) 2329
acute lymphoblastic leukemia (2114) 2114
precursor cell lymphoblastic leukemia-lymphoma - genetics (2112) 2112
precursor cell lymphoblastic leukemia-lymphoma - pathology (2104) 2104
middle aged (2068) 2068
treatment outcome (2040) 2040
prognosis (1871) 1871
precursor cell lymphoblastic leukemia-lymphoma - therapy (1803) 1803
precursor cell lymphoblastic leukemia-lymphoma - complications (1699) 1699
acute lymphoblastic-leukemia (1691) 1691
remission induction (1680) 1680
therapy (1616) 1616
acute lymphocytic leukemia (1564) 1564
precursor cell lymphoblastic leukemia-lymphoma - mortality (1384) 1384
antineoplastic agents - therapeutic use (1380) 1380
aged (1236) 1236
risk factors (1209) 1209
recurrence (1192) 1192
antineoplastic combined chemotherapy protocols - adverse effects (1102) 1102
childhood (1035) 1035
retrospective studies (1030) 1030
animals (1013) 1013
young adult (1002) 1002
precursor cell lymphoblastic leukemia-lymphoma - metabolism (997) 997
precursor cell lymphoblastic leukemia-lymphoma - diagnosis (990) 990
care and treatment (965) 965
follow-up studies (926) 926
disease-free survival (911) 911
research (911) 911
methotrexate - administration & dosage (907) 907
transplantation (877) 877
acute lymphatic leukemia (836) 836
combined modality therapy (831) 831
cell line, tumor (801) 801
survival rate (767) 767
acute myeloid-leukemia (765) 765
leukemia, myeloid, acute - drug therapy (760) 760
health aspects (757) 757
antineoplastic agents - adverse effects (748) 748
apoptosis (740) 740
minimal residual disease (733) 733
precursor cell lymphoblastic leukemia-lymphoma - blood (723) 723
vincristine - administration & dosage (714) 714
mice (707) 707
expression (695) 695
risk (687) 687
time factors (661) 661
methotrexate (658) 658
acute lymphocytic-leukemia (657) 657
precursor cell lymphoblastic leukemia-lymphoma - immunology (650) 650
analysis (648) 648
genetic aspects (636) 636
asparaginase - administration & dosage (612) 612
antineoplastic combined chemotherapy protocols - administration & dosage (611) 611
relapse (606) 606
antineoplastic agents - pharmacology (599) 599
survival (591) 591
survival analysis (586) 586
cytarabine - administration & dosage (581) 581
precursor b-cell lymphoblastic leukemia-lymphoma - drug therapy (581) 581
pharmacology & pharmacy (574) 574
apoptosis - drug effects (547) 547
methotrexate - adverse effects (546) 546
bone marrow transplantation (545) 545
lymphatic leukemia (544) 544
diagnosis (535) 535
medicine & public health (535) 535
immunology (522) 522
prospective studies (522) 522
dose-response relationship, drug (517) 517
acute disease (505) 505
all (494) 494
precursor cell lymphoblastic leukemia-lymphoma - radiotherapy (494) 494
drug therapy (493) 493
hematopoietic stem cell transplantation (491) 491
abridged index medicus (489) 489
cells (486) 486
drug resistance, neoplasm (476) 476
hematology, oncology and palliative medicine (476) 476
precursor t-cell lymphoblastic leukemia-lymphoma - drug therapy (462) 462
immunophenotyping (453) 453
mutation (450) 450
asparaginase - adverse effects (449) 449
stem cells (448) 448
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12204) 12204
Chinese (253) 253
Japanese (210) 210
French (138) 138
Spanish (133) 133
Polish (120) 120
German (118) 118
Russian (86) 86
Portuguese (32) 32
Italian (24) 24
Czech (13) 13
Danish (11) 11
Dutch (11) 11
Hungarian (11) 11
Norwegian (9) 9
Serbian (8) 8
Turkish (5) 5
Romanian (4) 4
Finnish (3) 3
Hebrew (3) 3
Korean (3) 3
Swedish (3) 3
Slovak (2) 2
Bosnian (1) 1
Croatian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Haematologica (Roma), ISSN 1592-8721, 2007, Volume 92, Issue 5, pp. 612 - 618
...{at}ospedaliriuniti.bergamo.it Background and Objectives: The molecular analysis of minimal residual disease (MRD) may provide informaton on the risk of recurrence in patients with acute lymphoblastic leukemia... 
ALL | Allogeneic transplantation | MRD | Adult ALL | adult ALL | BONE-MARROW-TRANSPLANTATION | IMMUNOGLOBULIN | TIME QUANTITATIVE PCR | REARRANGEMENTS | CHILDREN | IMATINIB | EXPANSION | Ph | TARGETS | MALIGNANCIES | allogeneic transplantation | FUSION GENE TRANSCRIPTS | HEMATOLOGY | Translocation, Genetic | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Humans | Middle Aged | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - surgery | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Leukemia-Lymphoma, Adult T-Cell - drug therapy | Gene Deletion | Fusion Proteins, bcr-abl - blood | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - blood | Precursor Cell Lymphoblastic Leukemia-Lymphoma - blood | Basic Helix-Loop-Helix Transcription Factors - genetics | Hematopoietic Stem Cell Transplantation | Survival Rate | Combined Modality Therapy | Remission Induction | Adolescent | Survival Analysis | Oncogene Proteins, Fusion - blood | Kinetics | Transplantation Conditioning | Cohort Studies | Piperazines - administration & dosage | Clinical Trials as Topic - statistics & numerical data | Precursor Cell Lymphoblastic Leukemia-Lymphoma - surgery | Risk | Transplantation, Homologous | Neoplasm, Residual | Multicenter Studies as Topic | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Polymerase Chain Reaction | Adult | Female | Myeloid-Lymphoid Leukemia Protein - blood | Gene Rearrangement, B-Lymphocyte | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | T-Cell Acute Lymphocytic Leukemia Protein 1 | Leukemia-Lymphoma, Adult T-Cell - genetics | Leukemia-Lymphoma, Adult T-Cell - surgery | Pyrimidines - administration & dosage | Gene Rearrangement, T-Lymphocyte | Leukemia-Lymphoma, Adult T-Cell - mortality | Kaplan-Meier Estimate | Proto-Oncogene Proteins - genetics | Treatment Outcome | Leukemia-Lymphoma, Adult T-Cell - pathology | Imatinib Mesylate | Biomarkers, Tumor - blood | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Leukemia-Lymphoma, Adult T-Cell - blood | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Benzamides
Journal Article
Blood, ISSN 0006-4971, 07/2015, Volume 126, Issue 5, pp. 589 - 596
Journal Article
Blood, ISSN 1528-0020, 2011, Volume 118, Issue 8, pp. 2077 - 2084
Journal Article
Journal Article
Leukemia & Lymphoma, ISSN 1029-2403, 2011, Volume 52, Issue 6, pp. 1098 - 1107
Monoclonal antibody (MoAb)-based therapies have opened innovative treatment avenues that have impacted on the management of patients with both neoplastic and non-neoplastic hematological diseases... 
mean fluorescence intensity (MFI) | monoclonal antibody therapy | antigen expression | antibody binding capacity (ABC) | Acute lymphoid leukemia (ALL) | B-ALL | GEMTUZUMAB OZOGAMICIN | CHEMOIMMUNOTHERAPY | CHEMOTHERAPY | IN-VITRO | INDUCTION THERAPY | ONCOLOGY | RITUXIMAB | LYMPHOMA | MONOCLONAL-ANTIBODIES | HEMATOLOGY | EXPRESSION | Antigens, CD - immunology | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Flow Cytometry - methods | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Humans | Middle Aged | Child, Preschool | Antibodies, Monoclonal - therapeutic use | Sialic Acid Binding Ig-like Lectin 2 - immunology | Antigens, CD - metabolism | Young Adult | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Precursor Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Sialic Acid Binding Ig-like Lectin 2 - metabolism | Aged, 80 and over | Adult | Transcription, Genetic | Sialic Acid Binding Ig-like Lectin 3 | Child | Antibodies, Monoclonal - immunology | Antigens, Differentiation, Myelomonocytic - immunology | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - therapy | Antigens, CD19 - immunology | Antigens, CD20 - immunology | Immunophenotyping | Antigens, CD20 - metabolism | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - therapy | Reverse Transcriptase Polymerase Chain Reaction | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Oncogene Proteins, Fusion - genetics | Antigens, Differentiation, Myelomonocytic - metabolism | Adolescent | Aged | Antigens, CD19 - metabolism
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2014, Volume 371, Issue 11, pp. 1005 - 1015
BACKGROUND Philadelphia chromosome-like acute lymphoblastic leukemia (Ph-like ALL) is characterized by a gene-expression profile similar to that of... 
MEDICINE, GENERAL & INTERNAL | MODELS | B-CELL PRECURSOR | INHIBITOR THERAPY | IMATINIB | PEDIATRIC ACUTE LEUKEMIAS | GENE FUSION | EXPRESSION | ETV6-NTRK3 FUSION TRANSCRIPTS | CRLF2 | DELETION | Oligonucleotide Array Sequence Analysis | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Humans | Child, Preschool | Infant | Male | Young Adult | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Heterografts | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Adult | Female | DNA, Neoplasm - analysis | Receptors, Cytokine - metabolism | Child | Philadelphia Chromosome | Receptors, Cytokine - genetics | Signal Transduction - genetics | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Animals | Protein Kinase Inhibitors - therapeutic use | Adolescent | Survival Analysis | Mice | Polymorphism, Single Nucleotide | Genome, Human | Protein-Tyrosine Kinases - antagonists & inhibitors | Development and progression | Care and treatment | Genetic aspects | Research | Lymphocytic leukemia | Tyrosine metabolism | Cell proliferation | Tyk2 protein | Leukemia | Genes | Clinical trials | Oncology | Genomes | Kinases | Cell activation | Janus kinase 2 | Xenografts | Teenagers | Children | Adolescents | Protein-tyrosine kinase | Age | Tyrosine | Young adults | Genomic analysis | Acute lymphatic leukemia | Stat5 protein | Lymphatic leukemia | Gene expression | Philadelphia chromosome | Interleukin 7 receptors | Thymic stromal lymphopoietin | Lymphocytes B
Journal Article
Nature (London), ISSN 1476-4687, 2014, Volume 514, Issue 7523, pp. 513 - 517
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2016, Volume 375, Issue 8, pp. 740 - 753
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 376, Issue 9, pp. 836 - 847
Journal Article